Susquehanna International Group’s Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A BSX.PRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-25,000
Closed -$3.03M 13656
2023
Q1
$3.03M Hold
25,000
﹤0.01% 4312
2022
Q4
$2.87M Buy
25,000
+22,732
+1,002% +$2.51M ﹤0.01% 4085
2022
Q3
$230K Buy
+2,268
New +$240K ﹤0.01% 10490

Other funds holding BSX.PRA

Susquehanna International Group's BSX.PRA Position: Q2 2023 in Review

Susquehanna International Group sold out of Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A (BSX.PRA) in Q2 2023, closing a stake of 25,000 shares — an estimated $3.03M sold.

Susquehanna International Group first reported a position in BSX.PRA in Q3 2022 and held it in 3 quarters. The position peaked at $3.03M in Q1 2023. 1 fund tracked by Wall St. Rank holds BSX.PRA as of Q2 2023.

  • Susquehanna International Group reported no remaining Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A position as of Q2 2023 after selling out during the quarter.
  • Susquehanna International Group sold 25,000 Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A shares in Q2 2023, an estimated $3.03M.
  • Susquehanna International Group first reported a position in Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A in Q3 2022 and held it in 3 quarters.
  • Susquehanna International Group's Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A position peaked at $3.03M in Q1 2023.
  • 1 fund tracked by Wall St. Rank held Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A as of Q2 2023.

Based on Susquehanna International Group's 13F filing for Q2 2023, filed 11 Aug 2023.